Britannia Life Sciences Past Earnings Performance
Past criteria checks 0/6
Britannia Life Sciences has been growing earnings at an average annual rate of 7.7%, while the Professional Services industry saw earnings growing at 14.5% annually. Revenues have been growing at an average rate of 12.4% per year.
Key information
7.7%
Earnings growth rate
37.6%
EPS growth rate
| Professional Services Industry Growth | 14.5% |
| Revenue growth rate | 12.4% |
| Return on equity | -82.8% |
| Net Margin | -73.0% |
| Last Earnings Update | 30 Jun 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Britannia Life Sciences makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 24 | 7 | -5 | 4 | 0 |
| 31 Mar 24 | 8 | -5 | 4 | 0 |
| 31 Dec 23 | 7 | 2 | 4 | 0 |
| 30 Sep 23 | 7 | 1 | 4 | 0 |
| 30 Jun 23 | 7 | 2 | 3 | 0 |
| 31 Mar 23 | 6 | 5 | 4 | 0 |
| 31 Dec 22 | 7 | -1 | 4 | 0 |
| 30 Sep 22 | 7 | -11 | 4 | 0 |
| 30 Jun 22 | 7 | -13 | 4 | 0 |
| 31 Mar 22 | 7 | -15 | 4 | 0 |
| 31 Dec 21 | 7 | -10 | 3 | 0 |
| 30 Sep 21 | 5 | 0 | 2 | 0 |
| 30 Jun 21 | 3 | 0 | 1 | 0 |
| 31 Mar 21 | 1 | 0 | 1 | 0 |
Quality Earnings: L020 is currently unprofitable.
Growing Profit Margin: L020 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: L020 is unprofitable, but has reduced losses over the past 5 years at a rate of 7.7% per year.
Accelerating Growth: Unable to compare L020's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: L020 is unprofitable, making it difficult to compare its past year earnings growth to the Professional Services industry (-4.2%).
Return on Equity
High ROE: L020 has a negative Return on Equity (-82.79%), as it is currently unprofitable.